CrossRef 73. Mansky PJ, Grem J, Wallerstedt DB, Monahan BP, Blackman MR: Mistletoe and Gemcitabine in patients with advanced cancer: A model for the phase I study of botanicals and botanical-drug interactions in cancer therapy. Integr Cancer Ther 2003, 2: 345–352.PubMedCrossRef 74. Mahfouz MM, Ghaleb HA, Hamza MR, Fares L, Moussa L, Moustafua A, El-Za Wawy A, Kourashy L, Mobarak L, Saed S, Fouad F, Tony O, Tohamy A: Multicenter open labeled clinical study in advanced breast cancer patients. A preliminary report. Journal of the Egyptian Nat Cancer Inst 1999, 11: 221–227. 75. Mahfouz MM, Ghaleb HA, Zawawy A, Scheffler A: Significant

tumor reduction, improvement of pain and quality of life and normalization of sleeping patterns of cancer patients treated with a high dose of mistletoe. Ann Oncol 1998, 9: 129. 76. Finelli A, Limberg R: Mistel-Lektin bei Patienten mit Tumorerkrankungen. Medizin im Bild Diagnostik und Therapie im Bild 1998, 1: 1–8. 77. Portalupi E: Neoadjuvant SB202190 clinical trial treatment in HPV-related AZD1152 chemical structure CIN with Mistletoe preparation (Iscador). Dissertation Universität Pavia 1991/1992 1995. 78. Werner H, Mahfouz MM, Fares L, Fouad F, Ghaleb HA, Hamza MR, Kourashy L, Mobarak AL, Moustafa A, Saed S, Zaky O, Zawawy A, Fischer S, Scheer R, Scheffler A: Zur Therapie des malignen Pleuraergusses mit einem Mistelpräparat. Der Merkurstab

1999, 52: 298–301. 79. Stumpf C, Schietzel M: Intrapleurale Instillation eines Extraktes aus Viscum album [L.] zur Behandlung maligner Pleuraergüsse. Tumordiagnose u Therapie 1994, 57–62. 80. Friedrichson UKH: Intraperitoneal instillation of Viscum album (L.) extrat (mistletoe) Chorioepithelioma for therapy and malignant ascites. Unpublished. Department of Radiology/Oncology, Community Hospital of Herdecke, University Witten/Herdecke. 1995. 81. Knöpfl-Sidler F, Viviani A, Rist L, Hensel A: Human cancer cells exhibit in vitro individual AZD2281 receptiveness towards different mistletoe extracts. Pharmazie 2005, 60: 448–454.PubMed 82. Zuzak T, Rist L, Viviani A, Eggenschwiler J, Mol C, Riegert

U, Meyer U: Das Mistelpräparat Iscucin ® – Herstellung, Analytik, Wirkung in vitro. Der Merkurstab 2004, 57: 467–473. 83. Büssing A, Schietzel D, Schietzel M, Schink M, Stein GM: Keine Stimulation in vitro kultivierter Tumorzellen durch Mistellektin. Dtsch Zschr Onkol 2004, 36: 66–70.CrossRef 84. Burger AM, Mengs U, Kelter G, Schüler JB, Fiebig HH: No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extrakt in vitro . Anticancer Res 2003, 23: 3801–3806.PubMed 85. Ramaekers FC, Harmsma M, Tusenius KJ, Schutte B, Werner M, Ramos M: Mistletoe extracts (Viscum album L.) Iscador ® interact with the cell cycle machinery and target survival mechanisms in cancer cells. Medicina 2007, 67: 79–84. 86. Harmsma M, Gromme M, Ummelen M, Dignef W, Tusenius KJ, Ramaekers FC: Differential effects of Viscum album extract IscadorQu on cell cycle progression and apoptosis in cancer cells. Int J Oncol 2004, 25: 1521–1529.